Posts Tagged ‘Merck’

Shared Investigator Platform (SIP) Strengths And Struggles

At any given time, a principal investigator (PI) can be working on one or more studies for a single sponsor company, or multiple studies for multiple sponsors. Likewise, each sponsor runs its clinical trials its own way, using its preferred technology and processes. And, often times, the technology and/or processes differ from study to study, […]

Top 5 Pharma & Medical Device Blog Posts From September 2017

Now that October is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in September – they’re ranked in order of popularity, with number one being the most viewed piece. How Merck & Facebook Are […]

How Merck & Facebook Are Pushing The Bounds Of Patient Recruitment

In December 2016, my colleague wrote about various technologies that can help pharmaceutical and research organizations help recruit clinical trial subjects. One of the applications Param Singh, our director of clinical operations and connected health for life sciences, highlighted is called Antidote Match: “Antidote Match, which uses natural language processing, artificial intelligence, and an army […]

Why Pharma Execs Want A More Favorable Tax Climate

The idea of companies moving their businesses to other parts of the world to benefit from lower taxes is not new. Allergan, the maker of Botox® and other drugs, transferred its global headquarters from New Jersey to Ireland in 2013. Medtronic moved its headquarters to Ireland in 2015, once it completed the acquisition of Covidien, […]

[Guide] The State Of The Life Sciences Industry

Last year’s presidential election invoked a great deal of angst in the pharmaceutical industry, with the cost of drugs taking center stage for a good portion of some candidates’ campaigns. While the things candidates said they would do could very well be different from what they might actually do, their words and records were enough […]